Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 03, 2025 10:00 ET | Source: 4D Path

4D Path’s Physics-Inspired QPOR™ Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial

Trial analysis published in JNCI predicts residual cancer burden from baseline H&E slides using 4D Path's fully automated, treatment predictive platform
November 27, 2025 08:47 ET | Source: Research and Markets

CD73 Inhibitors Pipeline Report 2025: an Up-to-date Competitor Evaluation in the Field of Antibodies, RNA and Small Molecules in Research and Development Inhibiting CD73

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of CD73 Inhibitors" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about CD73 Inhibitors...
November 21, 2025 07:15 ET | Source: Organic Remedies

Organic Remedies Donates $20,000 to Support Pennsylvania Breast Cancer Survivors and Their Families

Organic Remedies, a PA medical marijuana organization, donated $20,000 to the PA Breast Cancer Coalition.
November 17, 2025 16:05 ET | Source: RadNet, Inc.

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow

Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations
November 03, 2025 05:54 ET | Source: Research and Markets

Breast Cancer Antibody Drug Conjugates Market Research 2025-2030: $7 Billion Market Led by Daiichi Sankyo and AstraZeneca, with Rising Competition from Roche, Pfizer/Seagen, ADC Therapeutics

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030" report has been added...
October 22, 2025 10:09 ET | Source: Research and Markets

Breast Cancer Pipeline Market Research 2025: 300+ Drugs Under Development, Including Innovative Approaches Like PROTACs, ADCs, and CDK Inhibitors

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report delivers in-depth insights into over 250...
October 22, 2025 08:30 ET | Source: Izotropic

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one...
October 22, 2025 07:00 ET | Source: Galera Therapeutics

Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million

Galera Therapeutics Announces Acquisition of Avasopasem and the Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
October 17, 2025 11:35 ET | Source: Wake Radiology UNC Health Rex

Wake Radiology Grows Breast Imaging Section with Five New Hires; Launches "We See the Difference" Campaign for Breast Cancer Awareness Month

Raleigh, N.C., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Wake Radiology UNC Health Rex, the largest outpatient imaging provider in the Triangle, today announced the continued expansion of its breast imaging...
October 15, 2025 01:00 ET | Source: Vara

Vara erhält CE-Zertifizierung als einzige KI für eine unabhängige Zweitbefundung in der Mammographie und expandiert in Europa

BERLIN, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Vara gab heute eine neue CE-Zertifizierung bekannt – die einzige künstliche Intelligenz (KI) auf dem Markt, welche als unabhängige Zweitbefundung sowohl im...